Apyx Medical Corp Restricted Cash and Cash Equivalents
Apyx Medical Corp (APYX) had Restricted Cash and Cash Equivalents of $0 as of 2018-12-31, per its 10-K filed 2019-03-14.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2020-05-08
- 2018-12-31: Restricted Cash and Cash Equivalents $0.00.
- 2018-09-30: Restricted Cash and Cash Equivalents $0.00.
- 2018-06-30: Restricted Cash and Cash Equivalents $660.00K.
- 2018-03-31: Restricted Cash and Cash Equivalents $660.00K.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-14 |
| 2018-09-30 | $0.00 10-Q/A · filed 2020-05-08 |
| 2018-06-30 | $660.00K 10-Q · filed 2018-08-01 |
| 2018-03-31 | $660.00K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $719.00K 10-Q/A · filed 2020-05-08 |
| 2017-09-30 | $779.00K 10-Q · filed 2017-11-03 |
| 2017-06-30 | $779.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $779.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $779.00K 10-K · filed 2018-03-13 |
| 2016-09-30 | $779.00K 10-Q · filed 2016-10-27 |
| 2016-06-30 | $779.00K 10-Q · filed 2016-08-02 |
| 2016-03-31 | $839.00K 10-Q · filed 2016-05-11 |
| 2015-12-31 | $839.00K 10-K · filed 2017-03-10 |
| 2015-09-30 | $839.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $839.00K 10-Q · filed 2015-08-07 |
| 2015-03-31 | $839.00K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $899.00K 10-K · filed 2016-03-18 |
| 2014-09-30 | $898.00K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $898.00K 10-Q · filed 2014-08-08 |
| 2014-03-31 | $898.00K 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |